Bioverativ Inc.
SEC CIK 1681689 · BIVV · last insider filing 2018-03-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Paglia Louis J | Director | filed 2017 - 2018 |
| Protopapas Anna | Director | filed 2017 - 2018 |
| Denner Alexander J | Director | filed 2017 - 2018 |
| Posner Brian S | Director | filed 2017 - 2018 |
| Germano Geno J | Director | filed 2017 - 2018 |
| Cox John | Director · Chief Executive Officer | filed 2016 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Harris Timothy J.R. | EVP, R & D | filed 2017 - 2018 |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeutics | filed 2016 - 2018 |
| Greene John | EVP, CFO and Treasurer | filed 2016 - 2018 |
| Brudnick Richard | EVP, Business Development | filed 2016 - 2018 |
| Celona Lucia | EVP, HR & Corp Commun. Officer | filed 2016 - 2018 |
| Difabio Andrea | EVP, Chief Legal Officer | filed 2016 - 2018 |
| Duvall Diantha | Chief Accounting Officer | filed 2017 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.